Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheterization, Swan-Ganz | 1 | 2016 | 14 | 0.530 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 19 | 0.520 |
Why?
|
| Aneurysm, False | 1 | 2016 | 46 | 0.510 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 90 | 0.500 |
Why?
|
| Heart Failure | 4 | 2018 | 867 | 0.460 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2011 | 3 | 0.390 |
Why?
|
| Vasopressins | 1 | 2011 | 15 | 0.380 |
Why?
|
| Hyponatremia | 1 | 2011 | 12 | 0.380 |
Why?
|
| Cardiac Myosins | 1 | 2025 | 22 | 0.240 |
Why?
|
| Uracil | 1 | 2025 | 30 | 0.240 |
Why?
|
| Benzylamines | 1 | 2025 | 29 | 0.240 |
Why?
|
| Hospital Mortality | 2 | 2018 | 846 | 0.200 |
Why?
|
| Rupture | 1 | 2016 | 23 | 0.130 |
Why?
|
| Fluoroscopy | 1 | 2016 | 61 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2025 | 750 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 116 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 330 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 180 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 332 | 0.110 |
Why?
|
| Acute Disease | 2 | 2016 | 658 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 306 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2011 | 19 | 0.100 |
Why?
|
| Benzazepines | 1 | 2011 | 21 | 0.100 |
Why?
|
| Prognosis | 2 | 2016 | 1572 | 0.090 |
Why?
|
| Benzamides | 1 | 2011 | 50 | 0.090 |
Why?
|
| Pyrroles | 1 | 2011 | 50 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2011 | 235 | 0.090 |
Why?
|
| Hospitalization | 1 | 2016 | 1287 | 0.080 |
Why?
|
| Aged | 5 | 2018 | 13358 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 442 | 0.080 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 27 | 0.060 |
Why?
|
| Aminophylline | 1 | 2005 | 5 | 0.060 |
Why?
|
| Urea | 1 | 2025 | 34 | 0.060 |
Why?
|
| Humans | 7 | 2025 | 59512 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 48 | 0.060 |
Why?
|
| Bradycardia | 1 | 2005 | 34 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 161 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2005 | 247 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2005 | 176 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2018 | 1915 | 0.050 |
Why?
|
| Female | 5 | 2018 | 30914 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2005 | 206 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 1554 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 674 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 5180 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 537 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3583 | 0.040 |
Why?
|
| Data Warehousing | 1 | 2018 | 8 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5100 | 0.040 |
Why?
|
| Risk Factors | 2 | 2018 | 5014 | 0.040 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 12 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 125 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 47 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 258 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 16278 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 307 | 0.030 |
Why?
|
| Animals | 1 | 2011 | 19654 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1029 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2016 | 352 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 841 | 0.030 |
Why?
|
| Male | 4 | 2018 | 27582 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2005 | 3 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2005 | 42 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2005 | 26 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2005 | 25 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2005 | 19 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 172 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 169 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 279 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 319 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 172 | 0.010 |
Why?
|
| United States | 1 | 2016 | 7530 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 513 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 796 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 2329 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 860 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 3102 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 15776 | 0.000 |
Why?
|